Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cancer diabetes
Show results for
Products
Services
Software

Companies

News
Articles
Books

Refine by
Date

  • Older

Cancer Diabetes Articles & Analysis

38 news found

Creative Proteomics Introduces Central Carbon Metabolism Analysis Service to Accelerate Metabolic Research   

Creative Proteomics Introduces Central Carbon Metabolism Analysis Service to Accelerate Metabolic Research  

Researchers have long recognized the importance of CCM in regulating cellular function and contributing to the understanding of various diseases, including cancer, diabetes, and neurodegenerative disorders. However, traditional methods of analyzing these complex metabolic networks have often fallen short, hindering progress in the field. ...

ByCreative Proteomics


Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

“TGen has long been a pioneer in the field of oncology precision medicine, and we’re looking forward to building on this partnership to help pave the way for single-molecule proteomics to deliver new insights in cancer research.” “We are excited to work with Nautilus in being able to characterize the proteome in DIPG to further our understanding of this ...

ByNautilus Biotechnology


Alfa Chemistry Newly Releases Phospholipids, Modified Lipids, and Functionalized Lipids

Alfa Chemistry Newly Releases Phospholipids, Modified Lipids, and Functionalized Lipids

Bioactive lipids are consistently involved in chronic inflammation for pathological characterization, such as cancer, diabetes, atherosclerosis, asthma, inflammatory bowel disease, as well as autoimmune and neurodegenerative disorders. ...

ByAlfa Chemistry


CD Bioparticles Announces Magnetofection Reagents for Gene Expression

CD Bioparticles Announces Magnetofection Reagents for Gene Expression

Gene expression and therapy involves the introduction of foreign nucleic acids into target cells to modify or compensate for gene defects, thereby treating diseases such as cancer, diabetes, autoimmune diseases, and infectious diseases. However, when exposed nucleic acids are removed fast, resulting in low rates of nonspecific biodistribution and cellular ...

ByCD Bioparticles


BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

About With a long-term experience in peptide manufacturing, synthesis, and analysis, BOC Sciences has gained fame in providing a series of peptides for diverse therapeutic areas, for instance, research on osteoporosis, cancer, cardiovascular disease, diabetes, and HIV. ...

ByBOC Sciences


A project led by Vaxdyn receives funding from Next Generation EU Funds

A project led by Vaxdyn receives funding from Next Generation EU Funds

Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing infections in individuals affected by chronic diseases of the lungs, liver, kidney, immunocompromised by several co-morbidities such as diabetes or cancer, and populations associated with nursing homes and ...

ByVaxdyn, S. L.


BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research   

BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research  

BOC Sciences provides an extensive list of peptides for research on diabetes, cancers, HIV, etc. Its peptides for cardiovascular research were firstly highlighted in the August report, even though it has been serving researchers in this field with many mighty peptides in practice for years. ...

ByBOC Sciences


Peptides for Diabetes Research—a Special Offer of BOC Sciences

Peptides for Diabetes Research—a Special Offer of BOC Sciences

Some peptides in the BOC Sciences inventory are also valued as critical tools in the R&D of drugs for type 2 diabetes. For instance, islet amyloid polypeptide (IAPP), a major component of the pancreatic amyloid deposits found in the pancreas of patients with type 2 diabetes, may be involved in the pathogenesis of type 2 diabetes. ...

ByBOC Sciences


Rani Therapeutics Unveils High-Capacity RaniPill Device for Oral Delivery of Biologics

Rani Therapeutics Unveils High-Capacity RaniPill Device for Oral Delivery of Biologics

An equally effective oral alternative could change the treatment paradigm for a number of patient populations, including those with autoimmune diseases, cancer, and diabetes. “Therapeutic drug development has yielded a vast array of molecular entities, including peptides, antibodies and oligonucleotides. ...

ByRani Therapeutics


CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment

CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment

CD Genomics launches fully-developed human mitochondrial DNA (mtDNA) sequencing for the study of mitochondrial genome-related diseases, such as diabetes, certain cancers, and mechanisms of aging. The mitochondrial genome contains genes essential for cellular energetics and survival. ...

ByCD Genomics


CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, $1.2M R44 Small Business Innovation Research (SBIR) Phase II grant on August 29, 2019. ...

ByCoapTech


NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Validation

NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Validation

” “NexImmune’s AIM platform has shown itself to be a powerful and novel technology for the activation of cancer-fighting T-cells, and complements Zephyr’s ability to identify optimal targets for the immune system across a range of cancer types. ...

ByNexImmune, Inc.


Our Alliance with Serum Institute Provides an Accelerated Entry into Vaccines

Our Alliance with Serum Institute Provides an Accelerated Entry into Vaccines

Our pioneering efforts in the development of biosimilar insulins and monoclonal antibodies have enabled us to serve several million patients in both developed and developing countries in chronic or non-communicable disease segments such as diabetes, cancer and auto-immune disorders. The COVID-19 pandemic has opened our eyes to the serious threat posed by viral ...

ByBiocon


The GRAM paper gives face to the AMR crisis - Vaxdyn’s comment about the GRAM paper

The GRAM paper gives face to the AMR crisis - Vaxdyn’s comment about the GRAM paper

The experts of the Anti-Microbial Resistance (AMR) world, including Vaxdyn’s researchers, have been warning about the entrance into a post-antibiotic era or the occurrence of a silent pandemic for years. However, the general public, including health practitioners, did not understand the message or underscored the magnitude of the problem. Recently, a vast network of AMR experts around the ...

ByVaxdyn, S. L.


Profacgen Helps Accelerate GPCR Study with Various Services

Profacgen Helps Accelerate GPCR Study with Various Services

GPCR screening and analysis technology is now widely used in new drug screening for infectious diseases, cardiovascular disease, mental illness, acquired immunodeficiency syndrome (AIDS), diabetes, cancer and so on. Based on years’ experience, Profacgen now provides a comprehensive list of services to help with its customers’ GPCR study. ...

ByProfacgen


Vaxdyn introduces its multi-pathogen vaccine candidate KapaVax at the World Vaccine Congress Europe

Vaxdyn introduces its multi-pathogen vaccine candidate KapaVax at the World Vaccine Congress Europe

Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing infections in individuals affected by chronic diseases of the lungs, liver, kidney, immunocompromised by several co-morbidities such as diabetes or cancer, and populations associated with nursing homes and ...

ByVaxdyn, S. L.


City of Hope and Osel Announce Exclusive License for Intellectual Property on the use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications

City of Hope and Osel Announce Exclusive License for Intellectual Property on the use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications

City of Hope®, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, and Osel, Inc., a company developing live biotherapeutic products (LBPs) for diseases linked to the disruption of the human microbiome, today announced that City of Hope has granted an exclusive worldwide license to Osel for ...

ByOsel Inc.


Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with Checkpoint Inhibitor (CPI) Therapy in Metastatic Renal Cell Carcinoma

Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with Checkpoint Inhibitor (CPI) Therapy in Metastatic Renal Cell Carcinoma

Osel Inc., a company developing live biotherapeutic products (LBPs) for diseases linked to the disruption of the human microbiome, announced today that City of Hope, a world-renowned independent cancer and diabetes research and treatment center, presented data from a Phase 1b trial showing that an LBP, CBM588 (Clostridium butyricum MIYAIRI 588® strain), plus ...

ByOsel Inc.


Honey, nature’s golden treasure

Honey, nature’s golden treasure

You have it on toast, you sweeten your tea with it, you use it as a substitute when baking, and one spoon full when that throat tickles!Yes, honey has been mankind’s best friend, second to dogs, for some time! Its history has been intertwined with that of human communities over the span of millennia. Humans have been able to recognise its amazing value as a nutritious food item, a sweetener ...

BySpeciality Fibres and Materials Ltd. (SFM)


Signifier® Medical Ushers In New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA® Device

Signifier® Medical Ushers In New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA® Device

Left untreated, obstructive sleep apnea can lead to serious complications such as hypertension, heart attack, glaucoma, diabetes, cancer, and cognitive and behavioral disorders. “Treatment of sleep apnea has been shown to be highly effective for patients as there is growing evidence that it improves symptoms, reduces blood pressure, improves glucose ...

BySignifier Medical Technologies Ltd

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT